Danger Signs in Heart Failure- Effects of Video Education
NCT ID: NCT03657459
Last Updated: 2025-05-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
746 participants
INTERVENTIONAL
2018-07-26
2022-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Symptom Care at Home-Heart Failure
NCT04347759
A Family Intervention for Improving Self-Care of Patients With Heart Failure
NCT00645489
Enhancing Caregiver Support for Heart Failure Patients: the CarePartner Study
NCT00555360
Trial of a Tailored Message Program to Implement CHF Guidelines
NCT00013026
Using Videos to Facilitate Advance Care Planning for Patients With Heart Failure
NCT01589120
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
usual care group
Usual care consists of patient's receiving a Heart Failure Handbook before hospital discharge + verbal education delivered by multiple care providers (including a group education class at 1 site). The handbook is consistent; however, verbal education may vary between care providers based on their knowledge and time available, and perceived patient needs
No interventions assigned to this group
video education group
Will receive usual care, plus will watch 2 short Wellflix, Inc. Danger Signs of Heart Failure videos (via iPAD) on dyspnea, fatigue + a Danger Sign "edema" video, when applicable. Each video describes how to recognize if the sign/symptom is new or worsening and how to self-manage at home (via diet, fluid management and activity instructions)
Danger Signs of Heart Failure Videos
Short (under 3 minutes each) videos on (a) recognition of dyspnea, fatigue and edema and (b) self-management of each (based on diet, fluid management and activities) that reflect patient behaviors
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Danger Signs of Heart Failure Videos
Short (under 3 minutes each) videos on (a) recognition of dyspnea, fatigue and edema and (b) self-management of each (based on diet, fluid management and activities) that reflect patient behaviors
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cognitively intact and able to view videos (adequate eyesight and hearing) with correction, if needed,
* Discharge to home, assisted living facility or to a family member's home and can control dietary sodium and fluids as needed,
* Willing to participate; which may require up to three (3) follow-up telephone calls post-discharge.
Exclusion Criteria
* Plans to discharge to skilled nursing facility or hospice care,
* Receiving home hospice or palliative care; or has a medical condition reflecting less than 1 year of survival (cachexia, end stage liver disease or cancer or non-ambulatory New York Heart Association functional class IV HF),
* Hospitalized but at admission, in New York Heart Association functional class I or II HF
* Post-cardiac transplantation or ventricular assist device placement,
* Currently enrolled in another experimental HF research study,
* Chronic renal failure and receiving chronic hemodialysis therapy for an estimated glomerular filtration rate \< 15 mL/minute/1.73 m2,
* A non-traditional form of HF (hypertrophic or restrictive forms of cardiomyopathy, congenital heart disease or Takotsubo cardiomyopathy).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wellflix, Inc.
UNKNOWN
The Cleveland Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nancy M. Albert, Ph.D.
Assocaite Chief Nursing Officer-Resaerch and Senior Nurse Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
NANCY M. ALBERT, PhD
Role: PRINCIPAL_INVESTIGATOR
The Cleveland Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical Center Navicent Health
Macon, Georgia, United States
Cleveland Clinic Fairview Hospital
Cleveland, Ohio, United States
Cleveland Clinic main campus
Cleveland, Ohio, United States
Cleveland Clinic Marymount Hospital
Garfield Heights, Ohio, United States
Cleveland Clinic Hillcrest Hospital
Mayfield Heights, Ohio, United States
Cleveland Clinic Medina Hospital
Medina, Ohio, United States
Cleveland Clinic South Pointe Hospital
Warrensville Heights, Ohio, United States
WellSpan Health
York, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-442
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.